Process Chemistry in Antiviral Research (Q38997200)

8 September 2017

1 reference

title

Process Chemistry in Antiviral Research (English)

1 reference

8 September 2017

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27807768 AND SRC:MED&resulttype=core&format=json

4 June 2020

author name string

Nobuyoshi Yasuda

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27807768 AND SRC:MED&resulttype=core&format=json

4 June 2020

Hongming Li

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27807768 AND SRC:MED&resulttype=core&format=json

4 June 2020

Mark McLaughlin

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27807768 AND SRC:MED&resulttype=core&format=json

4 June 2020

David Tschaen

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27807768 AND SRC:MED&resulttype=core&format=json

4 June 2020

publication date

2 November 2016

1 reference

Topics in Current Chemistry

8 September 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27807768 AND SRC:MED&resulttype=core&format=json

4 June 2020

volume

374

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27807768 AND SRC:MED&resulttype=core&format=json

4 June 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27807768 AND SRC:MED&resulttype=core&format=json

4 June 2020

page(s)

77

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27807768 AND SRC:MED&resulttype=core&format=json

Structural and functional studies of archaeal viruses

4 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1007/S41061-016-0076-5

Here a virus, there a virus, everywhere the same virus?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S41061-016-0076-5

The ancient Virus World and evolution of cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S41061-016-0076-5

Achievements and challenges in antiviral drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S41061-016-0076-5

Isolation, structural characterization, and antiviral activity of positional isomers of monopegylated interferon alpha-2a (PEGASYS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S41061-016-0076-5

Synthesis and antiviral evaluation of N-carboxamidine-substituted analogues of 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamidine hydrochloride

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S41061-016-0076-5

Discovery of ABT-267, a pan-genotypic inhibitor of HCV NS5A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S41061-016-0076-5

Synthesis and structure-property evaluation of cellulose ω-carboxyesters for amorphous solid dispersions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S41061-016-0076-5

Structure-activity relationships of diamine inhibitors of cytochrome P450 (CYP) 3A as novel pharmacoenhancers, part I: core region

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S41061-016-0076-5

Epoxyalcohol route to hydroxyethylene dipeptide isosteres. Stereodivergent synthesis of the diamino alcohol core of ritonavir and its C-2 epimer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S41061-016-0076-5

Discovery of ledipasvir (GS-5885): a potent, once-daily oral NS5A inhibitor for the treatment of hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S41061-016-0076-5

Structure-activity relationship study on a novel series of cyclopentane-containing macrocyclic inhibitors of the hepatitis C virus NS3/4A protease leading to the discovery of TMC435350.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S41061-016-0076-5

In vitro and in vivo isotope effects with hepatitis C protease inhibitors: enhanced plasma exposure of deuterated telaprevir versus telaprevir in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S41061-016-0076-5

Challenges in modern drug discovery: a case study of boceprevir, an HCV protease inhibitor for the treatment of hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S41061-016-0076-5

Stereoselective addition of 2-phenyloxazol-4-yl trifluoromethanesulfonate to N-sulfinyl imines: application to the synthesis of the HCV protease inhibitor boceprevir

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S41061-016-0076-5

Discovery of (1R,5S)-N-[3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl]- 3-[2(S)-[[[(1,1-dimethylethyl)amino]carbonyl]amino]-3,3-dimethyl-1-oxobutyl]- 6,6-dimethyl-3-azabicyclo[3.1.0]hexan-2(S)-carboxamide (SCH 503034), a selective, potent, orally bio

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S41061-016-0076-5

Evolution of anti-HIV drug candidates. Part 3: Diarylpyrimidine (DAPY) analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S41061-016-0076-5

Inhibition of HIV-1 Replication by a Nonnucleoside Reverse Transcriptase Inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S41061-016-0076-5

In search of a novel anti-HIV drug: multidisciplinary coordination in the discovery of 4-[[4-[[4-[(1E)-2-cyanoethenyl]-2,6-dimethylphenyl]amino]-2- pyrimidinyl]amino]benzonitrile (R278474, rilpivirine).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S41061-016-0076-5

Synthesis of novel diarylpyrimidine analogues and their antiviral activity against human immunodeficiency virus type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S41061-016-0076-5

Tipranavir (PNU-140690): A Potent, Orally Bioavailable Nonpeptidic HIV Protease Inhibitor of the 5,6-Dihydro-4-hydroxy-2-pyrone Sulfonamide Class∇

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S41061-016-0076-5

Asymmetric allylboration of acyl imines catalyzed by chiral diols

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S41061-016-0076-5

Carbamoyl pyridone HIV-1 integrase inhibitors 3. A diastereomeric approach to chiral nonracemic tricyclic ring systems and the discovery of dolutegravir (S/GSK1349572) and (S/GSK1265744).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S41061-016-0076-5

Quinolone carboxylic acids as a novel monoketo acid class of human immunodeficiency virus type 1 integrase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S41061-016-0076-5

Discovery of raltegravir, a potent, selective orally bioavailable HIV-integrase inhibitor for the treatment of HIV-AIDS infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S41061-016-0076-5

Cobicistat (GS-9350): A Potent and Selective Inhibitor of Human CYP3A as a Novel Pharmacoenhancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S41061-016-0076-5

Structure-activity relationships of diamine inhibitors of cytochrome P450 (CYP) 3A as novel pharmacoenhancers. Part II: P2/P3 region and discovery of cobicistat (GS-9350).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S41061-016-0076-5

BMS-200475, a novel carbocyclic 2′-deoxyguanosine analog with potent and selective anti-hepatitis B virus activity in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S41061-016-0076-5

L-thymidine is phosphorylated by herpes simplex virus type 1 thymidine kinase and inhibits viral growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S41061-016-0076-5

Pathogenesis of hepatitis C-associated hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S41061-016-0076-5

The global burden of hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S41061-016-0076-5

Treatment of chronic hepatitis C infection: one step at a time

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S41061-016-0076-5

Pegylated-interferon-α(2a) in clinical practice: how to manage patients suffering from side effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S41061-016-0076-5

Nucleotide polymerase inhibitor sofosbuvir plus ribavirin for hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S41061-016-0076-5

Design, synthesis, and antiviral activity of 2'-deoxy-2'-fluoro-2'-C-methylcytidine, a potent inhibitor of hepatitis C virus replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S41061-016-0076-5

Discovery of a β-d-2′-Deoxy-2′-α-fluoro-2′-β-C-methyluridine Nucleotide Prodrug (PSI-7977) for the Treatment of Hepatitis C Virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S41061-016-0076-5

An efficient and diastereoselective synthesis of PSI-6130: a clinically efficacious inhibitor of HCV NS5B polymerase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S41061-016-0076-5

A general and enantioselective approach to pentoses: a rapid synthesis of PSI-6130, the nucleoside core of sofosbuvir

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S41061-016-0076-5

A general approach to the enantioselective α-oxidation of aldehydesvia synergistic catalysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S41061-016-0076-5

The stereospecific synthesis of P-chiral biophosphates and their analogues by the Stec reaction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S41061-016-0076-5

Stereocontrolled synthesis of oligonucleotide analogs containing chiral internucleotidic phosphorus atoms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S41061-016-0076-5

Synthesis of Diastereomerically Pure Nucleotide Phosphoramidates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S41061-016-0076-5

Grazoprevir-Elbasvir Combination Therapy for Treatment-Naive Cirrhotic and Noncirrhotic Patients With Chronic Hepatitis C Virus Genotype 1, 4, or 6 Infection: A Randomized Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S41061-016-0076-5

Discovery of MK-5172, a Macrocyclic Hepatitis C Virus NS3/4a Protease Inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S41061-016-0076-5

Macrocyclic drugs and synthetic methodologies toward macrocycles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S41061-016-0076-5

Development of a practical, asymmetric synthesis of the hepatitis C virus protease inhibitor MK-5172.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S41061-016-0076-5

Discovery of MK-8742: an HCV NS5A inhibitor with broad genotype activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S41061-016-0076-5

Axially chiral dicarboxylic acid catalyzed activation of quinone imine ketals: enantioselective arylation of enecarbamates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S41061-016-0076-5

A doubly axially chiral phosphoric acid catalyst for the asymmetric tandem oxyfluorination of enamides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S41061-016-0076-5

Enantioselective synthesis of an HCV NS5a antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S41061-016-0076-5

21 January 2018

How does HIV cause AIDS?

1 reference

https://api.crossref.org/works/10.1007/S41061-016-0076-5

Emerging concepts in the immunopathogenesis of AIDS

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S41061-016-0076-5

Discovery and selection of TMC114, a next generation HIV-1 protease inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S41061-016-0076-5

Potent HIV protease inhibitors incorporating high-affinity P2-ligands and (R)-(hydroxyethylamino)sulfonamide isostere

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S41061-016-0076-5

Efficient synthesis of (3R,3aS,6aR)- hexahydrofuro[2,3-b]furan-3-ol from glycolaldehyde.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S41061-016-0076-5

BCX-1812 (RWJ-270201): discovery of a novel, highly potent, orally active, and selective influenza neuraminidase inhibitor through structure-based drug design

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S41061-016-0076-5

Systematic structure-based design and stereoselective synthesis of novel multisubstituted cyclopentane derivatives with potent antiinfluenza activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S41061-016-0076-5

Stereoselective Hydroazidation of Amino Enones: Synthesis of the Ritonavir/Lopinavir Core

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S41061-016-0076-5

10.1007/S41061-016-0076-5

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27807768 AND SRC:MED&resulttype=core&format=json

4 June 2020

1 reference